Changchun High-Tech Industry (000661.SZ): Application for clinical trial of GenSci143 for injection accepted.

Changchun High-Tech Industry (000661.SZ) announced that its subsidiary, Changchun GenSci Pharmaceutical Co., Ltd. ("GenSci Pharmaceutical"), has received a written notification from the Food and Drug Administration of the United States (FDA) that its clinical trial application for injection of GenSci143 has been accepted, with indications for late-stage solid tumors.